Discovery of novel inhibitors for human farnesyltransferase (hFTase) via structure-based virtual screening†
Abstract
In this study, 22 novel hFTase
* Corresponding authors
a
State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China
E-mail:
huangjin@ecust.edu.cn, hlli@ecust.edu.cn
Fax: +86-21-64250213
Tel: +86-21-64250213
In this study, 22 novel hFTase
If you are not the author of this article and you wish to reproduce material from it in a third party non-RSC publication you must formally request permission using Copyright Clearance Center. Go to our Instructions for using Copyright Clearance Center page for details.
Authors contributing to RSC publications (journal articles, books or book chapters) do not need to formally request permission to reproduce material contained in this article provided that the correct acknowledgement is given with the reproduced material.
Reproduced material should be attributed as follows:
If the material has been adapted instead of reproduced from the original RSC publication "Reproduced from" can be substituted with "Adapted from".
In all cases the Ref. XX is the XXth reference in the list of references.
If you are the author of this article you do not need to formally request permission to reproduce figures, diagrams etc. contained in this article in third party publications or in a thesis or dissertation provided that the correct acknowledgement is given with the reproduced material.
Reproduced material should be attributed as follows:
If you are the author of this article you still need to obtain permission to reproduce the whole article in a third party publication with the exception of reproduction of the whole article in a thesis or dissertation.
Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.
Fetching data from CrossRef.
This may take some time to load.